PlainPharmaWatch

CMS Open Payments · Program Year 2024

Genesys Orthopedics Systems, L.L.C.

Genesys Orthopedics Systems, L.L.C. reported $837,199.98 across General Payments, Research, and Ownership to 550 physicians and teaching hospitals across 550 transactions.

See the rankings → How this is sourced
$837.2K
All-tracks total
550
Transactions
550
Recipients
−$65.6K
General Payments vs PY2023

Genesys Orthopedics Systems, L.L.C. reported $837,199.98 across all CMS Open Payments tracks (General + Research + Ownership) to 550 physicians and teaching hospitals in Program Year 2024 - ranking #661 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $837,199.98, averaging $1.5K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer genesys-orthopedics-systems-l-l-c Genesys Orthopedics Systems, L.L.C.

$837.2K · #661/1,925 · 0.0% industry · PY2024

  • TOT $837.2K
  • RANK #661
  • SHARE 0.0%
  • TXN 550
  • RCP 550
  • CAT 5
  • GEN $837.2K
  • ΔGEN −$65.6K
  • TOP1 25.8%
  • PY 2024

Volume peers

Nearest volume peer: Provepharm Inc. ($837.3K)

BIOTRONIK NRO, Inc.$843.1KProvepharm Inc.$837.3KGenesys Orthopedics Systems,…$837.2KVertos Medical, Inc.$836.6KSpineart USA Inc$830.2K
All-tracks payment totals near Genesys Orthopedics Systems, L.L.C. (CMS Open Payments PY2024)

Genesys Orthopedics Systems, L.L.C. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Genesys Orthopedics Systems, L.L.C.'s CMS-reported General Payments decreased by $65.6K (−7.3%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: GENESYS ORTHOPEDICS SYSTEMS, L.L.C.PY2023: GENESYS ORTHOPEDICS SYSTEMS, L.L.C.PY2024: Genesys Orthopedics Systems, L.L.C.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$902.8KPY2024$837.2K
PY2023
$902,828.70
PY2024
$837,199.98

What the Data Shows for Genesys Orthopedics Systems, L.L.C.

Genesys Orthopedics Systems, L.L.C. ranks #661 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $837,199.98 across 550 transactions to 550 physicians and teaching hospitals - $1.5K per transaction and $1.5K per recipient on average.

Of the 5 general-payment categories charted below, "Royalty or License" is the largest at $530.9K across 175 transactions, 63.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Royalty or License" leads Genesys Orthopedics Systems, L.L.C.'s 5-category general-payment breakdown at $530.9K, 63.4% of the reported total.

Genesys Orthopedics Systems, L.L.C. reports 5 general-payment categories - the top three are Royalty or License (63.4%), Consulting Fee (28.4%), and Travel and Lodging (5.6%). The remaining 2 categories make up 2.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Genesys Orthopedics Systems, L.L.C. divides its payments

General-payment categories, ordered by reported total

1. Royalty or License$530.9K2. Consulting Fee$238.0K3. Travel and Lodging$46.7K4. Food and Beverage$21.0K5. Gift$510.00
Payment Type Amount Transactions
Royalty or License $530.9K 175
Consulting Fee $238.0K 49
Travel and Lodging $46.7K 150
Food and Beverage $21.0K 140
Gift $510.00 36

Recipient Concentration in General Payments

The five largest recipient relationships account for $466,501.01 (55.7%) of $837,199.98 in this company's General Payments records across 70 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Genesys Orthopedics Systems, L.L.C.

The five named recipients with the highest reported General Payments from this company

Koijan Singh Kainth Md$216.0KKaywan Dinyar Gamadia Do$89.7KDouglas P Beall MD$66.1KEDWARD Lee Smith MD$48.0KMaahir Ul Haque Md$46.7K
  1. 1

    Koijan Singh Kainth Md

    $216,000.00 across 12 reported transactions

  2. 2

    Kaywan Dinyar Gamadia Do

    $89,679.41 across 13 reported transactions

  3. 3

    Douglas P Beall MD

    $66,091.20 across 43 reported transactions

  4. 4

    EDWARD Lee Smith MD

    $48,000.00 across 6 reported transactions

  5. 5

    Maahir Ul Haque Md

    $46,730.40 across 21 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Genesys Orthopedics Systems, L.L.C.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Genesys Orthopedics Systems, L.L.C..

Cardinal Health 200 LLC

HHI 1024

I/O Urology Corp.

HHI 1025

Bioprotect Medical, Inc.

HHI 1025

Recor Medical Inc

HHI 1026

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Genesys Orthopedics Systems, L.L.C..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Genesys Orthopedics Systems, L.L.C.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.